303 related articles for article (PubMed ID: 12416943)
1. Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy.
Shafran SD; Mashinter LD; Phillips P; Lalonde RG; Gill MJ; Walmsley SL; Toma E; Conway B; Fong IW; Rachlis AR; Williams KE; Garber GE; Schlech WF; Smaill F; Pradier C
Ann Intern Med; 2002 Nov; 137(9):734-7. PubMed ID: 12416943
[TBL] [Abstract][Full Text] [Related]
2. Discontinuation of secondary prophylaxis in AIDS patients with disseminated non-tuberculous mycobacteria infection.
Liao CH; Chen MY; Hsieh SM; Sheng WH; Hung CC; Chang SC
J Microbiol Immunol Infect; 2004 Feb; 37(1):50-6. PubMed ID: 15060688
[TBL] [Abstract][Full Text] [Related]
3. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?
Lange CG; Woolley IJ; Brodt RH
Drugs; 2004; 64(7):679-92. PubMed ID: 15025543
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
[TBL] [Abstract][Full Text] [Related]
5. [AIDS-related Mycobacterium avium infection dissemination in a patient with endobronchial lesions associated with immune reconstitution inflammatory syndrome].
Ogawa E; Murata M; Ohnishi H; Tatsukawa M; Sawayama Y; Furusyo N; Hayashi J
Kansenshogaku Zasshi; 2008 Jul; 82(4):341-6. PubMed ID: 18697487
[TBL] [Abstract][Full Text] [Related]
6. Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy.
Aberg JA; Yajko DM; Jacobson MA
J Infect Dis; 1998 Nov; 178(5):1446-9. PubMed ID: 9780266
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.
Karakousis PC; Moore RD; Chaisson RE
Lancet Infect Dis; 2004 Sep; 4(9):557-65. PubMed ID: 15336223
[TBL] [Abstract][Full Text] [Related]
8. Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents.
Cinti SK; Kaul DR; Sax PE; Crane LR; Kazanjian PH
Clin Infect Dis; 2000 Mar; 30(3):511-4. PubMed ID: 10722436
[TBL] [Abstract][Full Text] [Related]
9. Cerebral mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated mycobacterium avium complex infection.
Murray R; Mallal S; Heath C; French M
Eur J Clin Microbiol Infect Dis; 2001 Mar; 20(3):199-201. PubMed ID: 11347672
[TBL] [Abstract][Full Text] [Related]
10. Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.
Zeller V; Truffot C; Agher R; Bossi P; Tubiana R; Caumes E; Jouan M; Bricaire F; Katlama C
Clin Infect Dis; 2002 Mar; 34(5):662-7. PubMed ID: 11810599
[TBL] [Abstract][Full Text] [Related]
11. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of an AIDS patient with prolonged Mycobacterium avium bacteremia, high HIV RNA, HBV infection, Kaposi's sarcoma and cytomegalovirus retinitis.
Furukawa Y; Hamada H; Kamikawaji K; Unoki T; Inoue H; Tashiro Y; Okamoto M; Baba M; Hashiguchi T
J Infect Chemother; 2020 Feb; 26(2):279-281. PubMed ID: 31543435
[TBL] [Abstract][Full Text] [Related]
13. A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team.
Aberg JA; Williams PL; Liu T; Lederman HM; Hafner R; Torriani FJ; Lennox JL; Dube MP; MacGregor RR; Currier JS;
J Infect Dis; 2003 Apr; 187(7):1046-52. PubMed ID: 12660918
[TBL] [Abstract][Full Text] [Related]
14. Summaries for patients. Safety of stopping treatment for Mycobacterium avium complex infection in patients with AIDS.
Ann Intern Med; 2002 Nov; 137(9):I48. PubMed ID: 12416972
[No Abstract] [Full Text] [Related]
15. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis.
Jung Y; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Oh MD
Int J STD AIDS; 2017 Dec; 28(14):1426-1432. PubMed ID: 28592210
[TBL] [Abstract][Full Text] [Related]
16. Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy.
Rossi M; Flepp M; Telenti A; Schiffer V; Egloff N; Bucher H; Vernazza P; Bernasconi E; Weber R; Rickenbach M; Furrer H;
Swiss Med Wkly; 2001 Aug; 131(31-32):471-7. PubMed ID: 11641970
[TBL] [Abstract][Full Text] [Related]
17. Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy.
Kirk O; Reiss P; Uberti-Foppa C; Bickel M; Gerstoft J; Pradier C; Wit FW; Ledergerber B; Lundgren JD; Furrer H;
Ann Intern Med; 2002 Aug; 137(4):239-50. PubMed ID: 12186514
[TBL] [Abstract][Full Text] [Related]
18. Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS.
El-Sadr WM; Burman WJ; Grant LB; Matts JP; Hafner R; Crane L; Zeh D; Gallagher B; Mannheimer SB; Martinez A; Gordin F
N Engl J Med; 2000 Apr; 342(15):1085-92. PubMed ID: 10766581
[TBL] [Abstract][Full Text] [Related]
19. Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study.
Pechère M; Opravil M; Wald A; Chave JP; Bessesen M; Sievers A; Hein R; von Overbeck J; Clark RA; Tortoli E
Arch Intern Med; 1995 Feb; 155(4):400-4. PubMed ID: 7848023
[TBL] [Abstract][Full Text] [Related]
20. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
Ward TT; Rimland D; Kauffman C; Huycke M; Evans TG; Heifets L
Clin Infect Dis; 1998 Nov; 27(5):1278-85. PubMed ID: 9827282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
